Great Valley Advisor Group, Inc. Imara Inc. Transaction History

Great Valley Advisor Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$3.73 - $5.2 $27,419 - $38,225	-7,351 Reduced 34.99%	13,660 $55,000
Q1 2022 Apr 20, 2022	SELL	$1.15 - $2.41 $1,839 - $3,856	-1,600 Reduced 7.08%	21,011 $40,000
Q4 2021 Feb 10, 2022	SELL	$2.25 - $4.05 $10,800 - $19,440	-4,800 Reduced 17.51%	22,611 $51,000
Q3 2021 Oct 14, 2021	SELL	$4.08 - $7.83 $19,584 - $37,584	-4,800 Reduced 14.9%	27,411 $112,000
Q2 2021 Jul 27, 2021	BUY	$6.78 - $9.04 $218,390 - $291,187	32,211 New	32,211 $254,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.